anonymous
Guest
anonymous
Guest
Nonsense. Amgen folks already at Incyte. Grow up.Bad: topicals are hard to price to make money/generic world, no derm heritage, low salaries, hard to launch anything with Covid restrictions
Good: good takeover candidate so get your equity up there, small company that hasn't been infected with Amgen, Novartis, Abbie types yet - so the first couple years you will be invented to sell/earn. After that, look for big Pharma bone heads to infiltrate and implement selling models, coaching guides, all the BS that kills culture but grows activity